.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In July 2026, Embody’s mix concentrated entirely in Beverage at 100.0% share, with category sales up 32.24% year over year and 5.69% month over month, while average price declined 1.23% YoY and the brand’s overall 24‑month sales trailed by 26.19%. The brand held rank 24 in Beverage in Ontario, pairing a 32.24% YoY sales increase with a 5.69% MoM lift, which, alongside a -1.23% YoY price move, indicates volume-led gains. The pattern implies that a single-category footprint is currently amplifying growth, but reliance on Beverage concentrates risk and caps cross-category upside.
With July 2026 sales growth of 32.24% YoY alongside a -1.23% YoY price shift and a 5.69% MoM uptick, Embody’s positioning leans toward value-accessible Beverage offerings rather than premium-priced expansion, and the rank 24 standing signals mid-pack visibility within the province’s Beverage set. Given a 100.0% category share and a -26.19% 24‑month trajectory, the recent momentum likely reflects tactical pricing and velocity lift rather than portfolio breadth; the implication is that sustaining rank advancement will depend on either continued price-to-velocity efficiency or selective category adjacency to diversify growth drivers.
Competitive Landscape
Embody sits at #24 in ON Beverage in July 2026, improving 4 ranks YoY from #28 while slipping 1 position versus April 2026’s #23; the brand’s best rank of #21 in December 2025 frames a two-step gap from peak to current. In the same window, Versus climbed from #3 to #1 with +18.09% YoY sales while XMG fell from #1 to #2 on a -37.17% YoY slide, and Mollo eased from #2 to #3 with -1.09% YoY—indicating that Embody’s modest rank gain amid top-tier reshuffling points to incremental share capture rather than breakout momentum.
Notable Products
CBD/THC Blood Orange + Rosemary Tea (40mg CBD, 2mg THC, 355ml) advanced 16% month over month to rank 2, while CBD/THC Peach + Ginger White Sparkling White Tea (40mg CBD, 2mg THC, 355ml) held rank 1 with a 4.4% lift, indicating momentum is shifting toward the follower even as the leader consolidates. With two Beverage SKUs occupying ranks 1 and 2 and one posting a mid-teens MoM rise versus a mid-single-digit gain for the other, the concentration at the top signals a beverage-led portfolio where incremental share may accrue faster to the challenger SKU. The leading SKU’s $18,538 in July 2026 sales paired with the runner-up’s double-digit MoM growth implies headroom in flavored tea formats rather than breadth expansion into new categories. The pattern suggests Embody is tilting toward deepening velocity in fewer Beverage SKUs rather than proliferating assortment, prioritizing scale on proven flavors.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
